Maryam koosha | Health Policy | Editorial Board Member

Published on by Health Scientists

Dr. Maryam koosha | Health Policy | Editorial Board Member

Associate Professor | Institiute for humanities and cultural studies | Iran

Maryam Koosha, PhD, is an accomplished scholar in social welfare whose research spans breast cancer care, women’s health, aging studies, and social policy analysis, with a particular focus on how structural, cultural, and socioeconomic dynamics shape health outcomes in Iran. Her work demonstrates a sustained commitment to integrating social sciences with public health to advance patient-centered care and evidence-informed policymaking. Dr. Koosha has contributed extensively to the understanding of breast cancer experiences, including screening strategies, supportive care needs, lifestyle-related risk factors, and coping behaviors, collaborating widely with medical, psychosocial, and public health researchers across multidisciplinary platforms. Her publications in reputable national and international journals reflect the breadth of her scholarship, covering systematic and scoping reviews, randomized clinical trial collaborations, qualitative studies, and policy development research. Beyond oncology, she has emerged as a leading voice in gerontology and social health, developing policy models for enhancing the social well-being of older adults, analyzing policy gaps, and offering strategic directions for strengthening support systems in the context of rapid demographic change and the feminization of aging. Her academic contributions extend to cultural studies, social discourse analysis, and comparative welfare research, reinforcing her role as a thinker who bridges theory and applied policy. Dr. Koosha’s body of work reflects meaningful societal impact, informing service delivery, shaping evidence-based interventions, and providing insight for future policy reforms aimed at promoting equity, resilience, and community-centered support structures. Through her interdisciplinary collaborations, rigorous scholarship, and focus on vulnerable populations, she continues to advance the understanding of how social welfare principles can improve health outcomes and quality of life within evolving social and cultural landscapes.

Profile: Google Scholar

Featured Publications

1. Omidi, Z., Koosha, M., Nazeri, N., Khosravi, N., Zolfaghari, S., & Haghighat, S. (2022). Status of breast cancer screening strategies and indicators in Iran: A scoping review.

2. Farajivafa, V., Khosravi, N., Rezaee, N., Koosha, M., & Haghighat, S. (2023). Effectiveness of home-based exercise in breast cancer survivors: A randomized clinical trial.

3. Khosravi, N., Nazeri, N., Farajivafa, V., Olfatbakhsh, A., Atashi, A., Koosha, M., … (2019). Supportive care of breast cancer patients in Iran: A systematic review.

4. Koosha, M., Haghighat, S., Karampoor, R., Shekarbeygi, A., Bahrami, A., … (2017). Evaluation of socio-economic status and its impact on coping behavior of patients with breast cancer.

5. Koosha, M., Hezarjaribi, J., Allameh, H., Panahi, M. A., & Lalegani, A. (2022). Designing a policy model for enhancing social health of the elderly.

Mai Kadry | Global Health | Editorial Board Member

Published on by Health Scientists

Assist. Prof. Dr. Mai Kadry | Global Health | Editorial Board Member 

Research Scientist | National Research Center | Egypt

Mai O. Kadry is a distinguished researcher at the National Research Centre in Giza, Egypt, recognized for her multidisciplinary contributions across metabolomics, molecular oncology, nanomedicine, toxicology, and women’s health research. Her scientific portfolio reflects a sustained commitment to unraveling the biochemical and molecular mechanisms underpinning complex diseases, with a particular focus on metabolic disorders, cancer progression, reproductive toxicology, and innovative therapeutic strategies. Through a substantial body of peer-reviewed publications, she has advanced understanding of how metabolic signatures, genomic interactions, and molecular signaling pathways can be leveraged to improve disease diagnosis, treatment response, and therapeutic safety. Her work frequently integrates serum metabolomics, network pharmacology, lipidomics, nanostructure-based drug delivery, and experimental validation models, enabling a comprehensive systems-level view of disease processes. She has collaborated extensively with national and international scientists, contributing to multidisciplinary studies on phytotherapeutics for endocrine disorders, nanoscale interventions to mitigate chemotherapeutic toxicity, and molecular crosstalk driving drug resistance in cancer cells. Her authorship and citation footprint reflect broad scholarly engagement, while her active participation in multi-institutional teams has supported knowledge exchange and capacity building within the biomedical research community. Kadry’s investigations into natural product therapeutics, oxidative brain injury mechanisms, autophagy regulation, and emerging RNA-based biomarkers contribute to public health and precision medicine, offering insights with potential translational relevance to women’s health, oncology, toxicology, and environmental exposure science. Collectively, her work demonstrates a strong commitment to scientific innovation, interdisciplinary integration, and the societal importance of developing safer, more effective therapeutic approaches that align with global health priorities. She has 462 citations from 50 documents with an h-index of 12.

Profiles: Scopus | ORCID

Featured Publications

1. Kadry, M., Author, A. A., Author, B. B., … (2025). Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: Insights from serum metabolomics, network pharmacology and experimental validation.

2. Kadry, M., & Author, A. A. (2025). Novel insights into SNORD-78 and miR-122-5P: The predicted diagnostic indexes of lung cancer—Drug-loaded liposome formulations competing methylcholanthrene-induced lung cancer.

3. Kadry, M., Author, A. A., Author, B. B., Author, C. C., & Author, D. D. (2025). Oxidative brain injury ascending from DMBA: Metabolomics and BRAF3/FKBR/A2m molecular signaling crosstalk.

4. Kadry, M., Author, A. A., Author, B. B., … (2025). Metabolomics integrated genomics approach: Understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1/EGFR/PI3K/PTEN crosstalk.

5. Kadry, M., Author, A. A., & Author, B. B. (2025). Titanium nanostructure mitigating doxorubicin-induced testicular toxicity in rats via regulating major autophagy signaling pathways.

Baloji Biaya Désiré | Public Health | Best Researcher Award

Published on by Health Scientists

Mr. Baloji Biaya Désiré | Public Health | Best Researcher Award 

PhD student | Official University of Mbujimayi | Democratic Republic of the Congo

BALOJI BIAYA Désiré is a distinguished doctoral researcher in public health at the Official University of Mbujimayi, recognized for his strong commitment to advancing healthcare systems and addressing the multifaceted challenges of public health in resource-limited settings. His academic and professional pursuits integrate rigorous quantitative and qualitative research methodologies to explore critical areas such as HIV management, acute malnutrition, epidemic disease control, and malaria prevention. As principal investigator of an influential study on HIV care perceptions in Mbujimayi, he led the conception, design, data collection, analysis, and interpretation, culminating in a publication that has contributed significantly to understanding patient experiences and healthcare barriers within the Democratic Republic of Congo. His collaborative engagements with national and international NGOs reflect a deep commitment to humanitarian service and evidence-based health policy development. Through these partnerships, he has played a pivotal role in translating field research into actionable strategies for improving access, retention, and quality of care in underserved populations. His scholarly work, disseminated through reputable international journals, underscores his dedication to community-centered research and global health equity. Beyond academic contributions, he is actively involved in professional networks such as the National Council of the Order of Physicians, the Union of Physicians of the Democratic Republic of Congo, and the Competence Intelligence Development Expertise Solidarity Group, where he advocates for ethical standards and capacity building among healthcare professionals. With a growing portfolio of research, consultancy projects, and ongoing innovation, BALOJI BIAYA Désiré continues to bridge the gap between scientific inquiry and real-world health solutions, making a measurable impact on public health policy, disease prevention, and community empowerment across Africa and beyond.

Profile: ORCID 

Featured Publications

1. Baloji, D., Ntambwe, G., Ntambua, A., Kidinda, W., Kazadi, M. B., Mpanya, A., Mukuna, B., Ngongo, L., Mjumbe, C., & Mutombo, A. K. (2025). Perceptions, challenges and barriers to HIV care in Mbujimayi in the East Kasai Province, DR Congo: A qualitative study. HIV/AIDS – Research and Palliative Care.

2. Baloji, D., Ntambwe, G., Mpanya, A., Mukuna, B. N., Tague, C., Mjumbe, C. K., Mutombo, A. K., & Lutumba, P. (2025). Correlates of viral load suppression among people living with HIV on antiretroviral treatment in Mbujimayi, Democratic Republic of Congo. Preprint.

3. Baloji Biaya, D., Freddy, K., Jean, L., & Lutumba, P. (2025). Diagnostic versus la prescription médicale des antipaludiques et antibiotiques: Attitude et pratiques des cliniciens à Kinshasa en République Démocratique du Congo. Revue Congolaise des Sciences & Technologies.

4. Baloji Biaya, D. (2021). Urgence sanitaire Covid-19: Perception du confinement en milieu urbain africain. International Journal of Educational Research (IJO).

5. Baloji Biaya, D., & Kouakou, E. (2020). Diseases associated to the treatment of malnutrition in children in developing countries: Case of the Wikong Therapeutic and Nutritional Intensive Care Unit in Democratic Republic of Congo. Acta Scientific Paediatrics,

Ehsan Arabzadeh | Public Health | Best Researcher Award

Published on by Health Scientists

Dr. Ehsan Arabzadeh | Public Health | Best Researcher Award

University faculty member | Baqiyatallah University of medical science | Iran

Dr. Ehsan Arabzadeh is a health scientist and researcher currently serving as Director of Research at Histogenotech Company, Tehran, Iran, with an academic background deeply rooted in exercise physiology and sports sciences. He earned his Bachelor’s degree in Physical Education and Sport Sciences from Ferdowsi University of Mashhad (2011), followed by a Master’s in Exercise Physiology from the University of Mazandaran (2013), and later completed his Ph.D. in Exercise Physiology at Urmia University (2018), where he was recognized as an Exceptional Talent scholar by the Iranian National Elite Foundation. His research focuses on molecular and cellular exercise physiology, exercise biochemistry, clinical exercise physiology, and the therapeutic role of herbal and nano-supplement interventions, with significant contributions to understanding cardiokines, myokines, adipokines, oxidative stress, neurodegeneration, and metabolic disorders. Dr. Arabzadeh has authored and co-authored numerous publications in high-impact journals such as Nutrition, Pflügers Archiv-European Journal of Physiology, Biogerontology, Gene, and Journal of Food Biochemistry, where his studies explored exercise’s role in liver disease, cardiovascular function, skeletal muscle adaptation, and neuroprotection. His scientific excellence has been recognized through prestigious honors, including membership in the Iranian National Elite Foundation (awarded to less than 0.3% of Iranian students) and the Shahid Tehrani Moghaddam Award in 2019, alongside sporting achievements such as silver medals in national badminton competitions. In addition to his research, Dr. Arabzadeh has teaching experience at Urmia and Mazandaran Universities and serves on editorial and peer-review boards of several scientific journals, further contributing to advancing the fields of exercise physiology and health sciences. He has 267 citations from 43 documents with an h-index of 10.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Arabzadeh, E., Samadian, Z., Tofighi, A., & Tolouei Azar, J. (2020). Alteration of follistatin-like 1, neuron-derived neurotrophic factor, and vascular endothelial growth factor in diabetic cardiac muscle after moderate-intensity aerobic exercise with insulin. Sport Sciences for Health.

2. Shirvani, H., & Arabzadeh, E. (2020). Metabolic cross-talk between skeletal muscle and adipose tissue in high-intensity interval training vs. moderate-intensity continuous training by regulation of PGC-1α. Eating and Weight Disorders.

3. Shirvani, H., Arabzadeh, E., & Akbari, J. (2020). The short-term effect of caffeine supplementation on immune-endocrine responses to acute intensive exercise / Effet à court terme d’une supplémentation en caféine sur les réponses immunitaires et endocriniennes à un exercice intense et bref. Science and Sports.

4. Shirvani, H., Aslani, J., Fallah Mohammadi, Z., & Arabzadeh, E. (2019). Short-term effect of low-, moderate-, and high-intensity exercise training on cerebral dopamine neurotrophic factor (CDNF) and oxidative stress biomarkers in brain male Wistar rats. Comparative Clinical Pathology.

5. Mirdar, S., Kazemzadeh, Y., Arabzadeh, E., Shirvani, H., & Hamidian, G. (2019). The effects of tapering with and without ethanolic extract of Nigella sativa on hypoxia inducible factor-1α and exercise-induced bronchial changes. Journal of Military Medicine.

Ritu Tiwari | Global Health | Best Researcher Award

Published on by Health Scientists

Dr. Ritu Tiwari | Global Health | Best Researcher Award

Scientific Officer at Indian Pharmacopoeia Commission, India

Dr. Ritu Tiwari is a highly accomplished researcher and scientific officer working with the Indian Pharmacopoeia Commission under the Ministry of Health and Family Welfare. Her work focuses on the development, validation, and quality assessment of phytopharmaceuticals, herbal drugs, and traditional formulations. She has made substantial contributions to drafting monographs for the Ayurvedic Pharmacopoeia and advancing analytical methodologies through regulatory and technical leadership. With expertise spanning pharmacognosy, phytochemistry, and analytical science, she has authored numerous impactful research papers in reputed journals and participated in global scientific events. Her active involvement in national committees, assessor roles, and software development projects underlines her dynamic and multidisciplinary capabilities. Her dedication to regulatory improvement and scientific excellence has earned her widespread recognition through national and international awards. She continues to influence health and pharmaceutical policy through her research and technical contributions, making her a compelling candidate for recognition in the field of pharmaceutical and herbal sciences.

Professional Profile

 Scopus Profile

Education

Dr. Ritu Tiwari possesses a unique blend of interdisciplinary academic qualifications that underpin her scientific expertise. She holds postgraduate degrees in botany and computer applications, supplemented by professional education in law and pedagogy. Further advancing her technical proficiency, she has acquired diplomas in chemical instrumentation, industrial hygiene, and software systems. Her doctoral research specialized in phytochemistry and pharmacognosy, equipping her with advanced knowledge in the characterization of plant-based medicinal compounds. This academic foundation has enabled her to understand complex biological systems and regulatory frameworks, integrating science, policy, and technology. Her diverse qualifications reflect a rare integration of natural sciences, legal acumen, and digital competency, supporting her multifaceted role in pharmaceutical standard-setting. Her educational background is not only academically rich but also deeply aligned with her professional responsibilities, making her well-positioned to contribute meaningfully to scientific innovation, regulatory advancement, and interdisciplinary collaboration within national and international health and pharmacological landscapes.

Experience

Dr. Ritu Tiwari has served for decades as a scientific officer with the Indian Pharmacopoeia Commission, where she plays a key role in ensuring the quality and safety of pharmaceuticals. Her responsibilities include the development and validation of testing methods for pharmaceutical products, including herbal and phytopharmaceutical formulations. She has been instrumental in preparing and verifying monographs and general chapters for national pharmacopoeias. Her professional journey reflects a deep engagement with regulatory science, public health, and quality control. She also actively contributes to technical dossier reviews, enabling the inclusion of scientifically backed formulations in official standards. In addition to her core responsibilities, she serves on technical committees and works with digital development teams to enhance pharmacopoeial documentation. Her experience spans laboratory science, method validation, and institutional policy development. Her comprehensive professional involvement reflects her strong commitment to maintaining scientific rigor in drug evaluation and her influence on regulatory systems and health policy.

Research Interest

Dr. Ritu Tiwari’s research interests lie in the fields of pharmacognosy, phytochemistry, and analytical method development, with a strong focus on herbal drug standardization and phytopharmaceuticals. She is particularly passionate about exploring the chemical and biological properties of medicinal plants, applying modern analytical tools such as chromatography and metabolomics to understand bioactive compounds. Her work also includes quality control studies that examine contaminants like pesticides, heavy metals, and aflatoxins in traditional medicines. In addition, she investigates the therapeutic potential of plant-based compounds for inflammatory, metabolic, and microbial disorders. A growing area of interest in her work includes the integration of quality-by-design principles in method development, regulatory science, and evidence-based traditional medicine. Her research is highly relevant to contemporary needs in pharmacological sciences, especially in enhancing the safety, efficacy, and global acceptance of traditional and herbal medicines. She is driven by the goal of bridging ancient knowledge with modern pharmaceutical standards.

Award and Honor

Dr. Ritu Tiwari has been recognized with several prestigious awards for her outstanding contributions to pharmaceutical science and herbal research. She received national acclaim through the Dr. P. D. Sethi Memorial HPTLC Award for excellence in analytical research. Her presentations at international conferences have earned her multiple honors, including best oral and poster presentations, highlighting the quality and impact of her work. She has been acknowledged for her research on bioactive compounds, regulatory science, and phytopharmaceutical development. Her awards span multiple disciplines and events, reflecting recognition from academic, scientific, and regulatory communities. These honors not only celebrate her technical skill and innovation but also emphasize her role in advancing public health through high-quality research. In addition to scientific recognition, her involvement in key conferences and workshops underscores her influence in professional development and knowledge dissemination. Her accolades are a testament to her sustained excellence and respected leadership in her field.

Research Skill

Dr. Ritu Tiwari possesses a broad range of research skills that contribute to her effectiveness as a scientist and technical expert. She is adept in analytical techniques such as high-performance thin-layer chromatography, high-performance liquid chromatography, and nuclear magnetic resonance spectroscopy, which she applies to identify and quantify active compounds in herbal and pharmaceutical products. She has expertise in metabolomic profiling, quality-by-design frameworks, and method validation processes. Her skills extend to pharmacognostic characterization and the evaluation of contaminants like heavy metals and pesticides. She is also experienced in preparing scientific dossiers, regulatory documentation, and pharmacopoeial monographs. Her capacity to integrate traditional knowledge with contemporary scientific methods enables her to contribute meaningfully to the field of phytopharmaceuticals. She has demonstrated strong capabilities in technical writing, scientific presentation, and software-supported data management. These competencies make her not only a highly skilled researcher but also a valuable contributor to national health and pharmacopoeial standards.

Publications Top Notes

Title: Mpox outbreak response: Regulatory and public health perspectives from India and the world
Authors: Ritu Tiwari, et al.
Year: 2025

Conclusion

Dr. Ritu Tiwari stands out as a deeply committed scientific officer, technical expert, and scholar whose contributions have significantly advanced India’s pharmacopoeial standards and phytopharmaceutical research. Her consistent publication output, interdisciplinary qualifications, regulatory insight, and numerous awards position her as an outstanding candidate for the Best Researcher Award. With continued expansion into international collaborations, innovation-led research, and public health policy contributions, she is poised to make even broader contributions to global health science. Therefore, she is highly deserving of this recognition.